Forum Ventures report: where health systems say innovation is most needed
The report outlined four areas as a guide to help startups to sell into these systems
Read more...At the end of 2011, there were rumblings about a startup bubble ready to burst. While no one really heard a big pop, it's been more like a hissing sound of a balloon deflating.
Investment in US venture-backed companies fell in the fourth quarter of last year as startups raised $6.6 billion from 733 companies, down 20% in capital and 17% in number of deals in the same perios the year prior, according to a newly-released report from Dow Jones. The quarterly amount is the lowest level since the third quarter of 2010.
Overall, venture capital investments tallied $29.7 billion for 3,363 deals, down 15% from 2011 when $35 billion poured into venture capital deals - the highest amount raised since 2001, and the third straight year of year-over-year growth.
The decade between has seen VC investments range from an average of $22 billion up to 2005, and then $29 billion from 2006 to 20012. So last year's range isn't particularly alarming.
Interestingly, the number of seed-stage deals as a percent of total deals was the highest its ever been (at least in the data collected since 2000). The ratio was 11.9% in 2012, up from 11.6% in 2011 and well north of the ratio in the last decade, which was roughly around 5%.
Another interesting tidbit, the stage of investment that saw the biggest drop was in what Dow Jones calls "second round" deals, which are Series B and C. Those deals saw a 27% drop to $4.9 billion in investments. The first round, or Series A rounds only saw a drop of 7% to $5.6 billion. Seed stage deals saw an 18% drop in investments, down to $287 million, while late-stage deals saw a 17% drop to $16.5 billion invested.
Also corporate investments saw its best year since 2000. Eight corporate deals received $200 million in the fourth quarter, a 32% increase in capital, despite a 50% drop in deals compared to year-ago levels.
(image source: leadingchangegroup)
Founder and CEO of Vator, a media and research firm for entrepreneurs and investors; Managing Director of Vator Health Fund; Co-Founder of Invent Health; Author and award-winning journalist.
All author postsThe report outlined four areas as a guide to help startups to sell into these systems
Read more...Flyte delivers mechanotherapy transvaginally to the pelvic floor
Read more...The country will need an additional 203,200 RNs each year until 2031 to fill staffing shortages
Read more...